FATUZZO, Pasquale Mario
 Distribuzione geografica
Continente #
NA - Nord America 8.750
EU - Europa 3.081
AS - Asia 2.487
SA - Sud America 576
AF - Africa 276
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 15.180
Nazione #
US - Stati Uniti d'America 8.442
SG - Singapore 1.273
CN - Cina 918
IE - Irlanda 803
UA - Ucraina 787
IT - Italia 733
BR - Brasile 510
CA - Canada 289
RU - Federazione Russa 223
CI - Costa d'Avorio 212
DE - Germania 180
SE - Svezia 98
IN - India 80
GB - Regno Unito 72
VN - Vietnam 71
FR - Francia 52
AR - Argentina 31
SN - Senegal 29
CH - Svizzera 23
BD - Bangladesh 22
UZ - Uzbekistan 22
AT - Austria 21
NL - Olanda 16
GR - Grecia 15
PL - Polonia 15
TR - Turchia 14
IQ - Iraq 13
MX - Messico 12
MA - Marocco 11
ZA - Sudafrica 11
ID - Indonesia 9
AL - Albania 8
EC - Ecuador 8
JP - Giappone 8
KR - Corea 8
FI - Finlandia 7
IR - Iran 7
LB - Libano 7
PY - Paraguay 7
CO - Colombia 6
ES - Italia 6
HK - Hong Kong 6
PK - Pakistan 6
NP - Nepal 5
AU - Australia 4
CL - Cile 4
EU - Europa 4
KE - Kenya 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
CZ - Repubblica Ceca 3
EG - Egitto 3
ET - Etiopia 3
HU - Ungheria 3
LT - Lituania 3
PE - Perù 3
VE - Venezuela 3
BG - Bulgaria 2
BO - Bolivia 2
DZ - Algeria 2
KW - Kuwait 2
OM - Oman 2
SA - Arabia Saudita 2
SM - San Marino 2
UY - Uruguay 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BN - Brunei Darussalam 1
DO - Repubblica Dominicana 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 15.180
Città #
Dallas 1.437
Houston 1.256
Santa Clara 984
Jacksonville 866
Dublin 802
Singapore 762
Chandler 712
Boardman 347
Chicago 292
Nanjing 268
Andover 234
Lawrence 233
Cambridge 231
Toronto 219
Abidjan 212
Ashburn 137
Des Moines 134
San Mateo 117
Catania 112
Wilmington 102
Grafing 93
Nanchang 81
Beijing 80
Shenyang 80
Saint Petersburg 76
Civitanova Marche 59
Hebei 57
Ottawa 51
Jiaxing 50
Council Bluffs 49
Los Angeles 46
Changsha 43
Hefei 41
Rome 41
Tianjin 38
Bremen 33
São Paulo 31
Dakar 29
Kochi 28
Milan 26
New York 23
Rio de Janeiro 23
Seattle 22
Ho Chi Minh City 21
Pune 20
The Dalles 20
Dong Ket 18
Brooklyn 17
Columbus 17
Moscow 17
Norwalk 15
Hangzhou 13
Florence 12
Padova 12
San Francisco 12
Boston 11
Hanoi 11
Kunming 11
Ningbo 11
Noto 11
Zhengzhou 11
Charlotte 10
Curitiba 10
Guarulhos 10
Liberty Lake 10
Nuremberg 10
Civitavecchia 9
Dhaka 9
Guangzhou 9
Jinan 9
London 9
Sorocaba 9
Belo Horizonte 8
Carlentini 8
Messina 8
Monteiasi 8
Montreal 8
Mumbai 8
Palermo 8
Recife 8
Seoul 8
Tokyo 8
Brasília 7
Munich 7
Porto Alegre 7
Tirana 7
Washington 7
Amsterdam 6
Ardabil 6
Atlanta 6
Bari 6
Cape Town 6
Casablanca 6
Caxias do Sul 6
Frankfurt Am Main 6
Praia Grande 6
Salvador 6
Taizhou 6
Vienna 6
Ann Arbor 5
Totale 11.113
Nome #
Para-perirenal distribution of body fat is associated with reduced glomerular filtration rate regardless of other indices of adiposity in hypertensive patients 915
Molecular and clinical studies in five index cases with novel mutations in the GLA gene 282
A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis 281
LA DIMETILARGININA ASIMMETRICA (ADMA) INTERAGISCE CON L’FGF-23 NEL PREDIRE LA PROGRESSIONE DEL DANNO RENALE NEI PAZIENTI CON STADIO 2-5 DI MALATTIA RENALE CRONICA 181
Microplastics exposure in dialysis patients: preliminary results of a case-control study 151
Anxiety, depression, chronic inflammation and aortic stiffness in Crohn’s disease: the brain-gut-vascular axis 140
ADPKD: valutazione di patologia cistica epididimaria e quadro spermatico 126
A systematic review of arterial stiffness, wave reflection and air pollution 116
Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease 114
Aferesi terapeutica in paziente con crioglobulinemia (contributo clinico) 112
Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention 109
Pazienti con insufficienza renale cronica: risultati dallo studio Nefrodata [Characteristics of patients with chronic kidney disease referred to a nephrology outpatient clinic: results of Nefrodata study] 108
AUDIT ITALIANO SUL CONTROLLO DELLA PRESSIONE ARTERIOSA (PA) NELLA INSUFFICIENZA RENALE CRONICA IN FASE CONSERVATIVA (IRC) 105
Aberrant right subclavian artery laceration due to internal jugular vein catheterization treated by stent -graft implantation 102
ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVELS IN CHRONIC KIDNEY DISEASE: A SALTY QUESTION? 99
Arteriovenous fistula and pre-surgery mapping: Potential role of physical exercise on endothelial function 99
Il Fosforo: nuovo fattore di rischio cardiovascolare? [Phosphorus: A new cardiovascular risk factor?] 96
Pulse wave velocity differs between ulcerative colitis and chronic kidney disease 95
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 95
Alterazioni carotidee nell’insufficienza renale cronica 92
Alterazioni carotidee in corso di insufficienza renale cronica 92
Asymmetric dimethylarginine (ADMA),left ventricular hypertrophy and systolic dysfunction in hemodialysis patients 91
Prevalence and prognosis of mild anemia in non-dialysis chronic kidney disease: A prospective cohort study in outpatient renal clinics 90
Eventi avversi e trigger C12: Stroke in ospedale 90
ACE and angiotensin genes and all-cause and cardiovascular mortality in dialysis patients 88
Soluble E-selectina is an marker of outcome in end renal disease and interacts with inflammation to determine cardiovascular risk 86
PLASMA CONCENTRATION OF ASYMMETRICAL DYMETHYLARGININE AND MORTALITY IN PATIENTS WITH END STAGE RENAL DISEASE: “A PROSPECTIVE STUDY” . 85
Utilità dell’sCD14-ST per la diagnosi di sepsi nel paziente con insufficienza renale [Usefulness of sCD14-ST in the diagnosis of sepsis in patient with renal failure] 82
Atrial Natriuretic Peptide (ANP), Brain Natriuretic Peptide (BNP) and Left Atrial Volume: a longitudinal study in End Stage Renal Disease (ESRD) patients. JASN 2008;19:719A. 82
Somatopsychic correlates and quality of life of the dialyzed patient: a cross-sectional study 82
Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients 81
An Unusual Association: Fahr's Syndrome And Chronic Kidney Disease 81
Arterial pressure determinant of LVH in uremic patients. 81
Wegener: nostro contributo clinico 81
Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease 81
Rapporti dei peptidi natriuretici con la struttura e la funzione cardiaca nell'insufficienza renale cronica terminale: analogie e differenze tra ANP, BNP, CNP e DNP. 80
Letter regarding the article "The impact of hypomagnesemia on erectile dysfunction in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a prospective cross-sectional study". 79
raised Asymmetric Dimethyl Arginine is Associated With High Plasma Norepinephrine in Patients with ESRD 79
LIVELLI PLASMATICI DELLE PENTRAXINE “SHORT” (PROTEINA C REATTIVA) E DELLE PENTRAXINE “LONG” (PTX3) NELLA INSUFFICIENZA RENALE E NEL TRATTAMENTO EMODIALITICO 79
Metformin and kidney 79
IL-1beta, TNF-alpha and IL-6 release from monocytes in haemodialysis patients in relation to dialytic age 78
AUDIT ITALIANO SUL CONTROLLO DELLA PRESSIONE ARTERIOSA (PA) NELLA INSUFFICIENZA RENALE CRONICA IN FASE CONSERVATIVA (IRC) 77
ACE and angiotensin genes and all-cause and cardiovascular mortality in dialysis patients. 77
Aspergillosis in Hemodialysis Patient 76
Peritonite da Candida e sepsi da Acinetobacter baumannii in dialisi peritoneale: una associazione con la prognosi non è sempre sfavorevole 75
DIAGNOSTIC POTENZIAL OF CARDIAC NATRIURETIC PEPTIDES IN DIALYSIS PATIENTS 75
L’IMMUNITÀ INNATA E LA PROGRESSIONE DELLA MALATTIA RENALE CRONICA 75
IL2 and its receptors in elderly subjects on hemodialysis 74
Review: UPDATE sul metabolismo del magnesio 74
ITALIAN AUDIT ON THERAPY OF HYPERTENSION IN CHRONIC KIDNEY DISEASE: TABLE-CKD STUDY 74
La PET con C-Metionina: un approccio propositivo nel trattamento dell'iperparatiroidismo 74
Vascular dysfunction in Cardiorenal Syndrome type 4 74
ADPKD:rilevanza del rischio cardio-vascolare in un gruppo di pazienti non complianti alla terapia antipertensiva. 73
Sepsi e Polimixina (contributo) 73
Norepinephrine and concentric hypertrophy in patients with end-stage renal disease 73
Comparative study of biochemical markers of bone formation in relation to different dialysis age 72
Heart rate, age and the risk progression to kidney failure in patients with CKD 72
Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism 72
L’interleuchina-6 è implicata in maniera causale nell’alto rischio cardiovascolare della malattia renale cronica: uno studio di randomizzazione mendeliana 72
Valutazione clinica dell'efficacia terapeutica dell'acebutololo nell'ipertensione arteriosa. 72
Combined use of ultrasound and GFR predictive equations for the estimation of renal function in elderly patients 72
Ascessi Renali:patologia emergente in soggetti di giovane età 72
Comportamento delle transaminasi sieriche in corso di infezione da HBV e HCV in pazienti emodializzati 71
Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients 71
Magnesium, calcium and potassium: "no one was born alone" 71
Il fumo, la pressione arteriosa e l'albuminemia sono fattori predittivi indipendenti dal danno vascolare negli uremici in dialisi 71
Complicanze tardive legate al posizionamento del catetere venoso centrale: le complicanze meccaniche 71
Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure 70
Valutazione non invasiva dei baroriflessi e della funzione carotidea nell'insufficienza renale: il sistema echotracking 69
Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage? 68
CHLAMYDIA PNEUMONIAE, OVERALL AND CARDIOVASCULAR MORTALITY IN END STAGE RENAL DISEASE 68
Soluble e-selectin is an inverse and independent predictor of left ventricular wall thickness in end-stage renal disease patients 68
Ruolo della Dialisi Peritoneale nel trattamento dei Pazienti con Scompenso Cardiaco Congestizio 68
Ultrasuoni versus rx nella dislocazione del catetere peritoneale: mito o raltà? 68
MANUALE ITALIANO DI CATETERISMO VENOSO CENTRALE IN NEFROLOGIA 68
LIVELLI DI PTX 3 IN PAZIENTI CON INSUFFICIENZA RENALE CRONICA (IRC) 68
Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression 68
Renal haemodynamics and coronary atherosclerotic burden are associated in patients with hypertension and mild coronary artery disease 68
Renal transplantation parenchymal complications: what Doppler ultrasound can and cannot do 67
Psichiatria di Liaison:Contributo sperimentale allo studio della Qualità di dei DializzatiVita 67
STUDIO SIR-SIN ( STUDIO ITALIANO INDICATORI DI RISULTATO MULTIPLI-EPIDEMIOLOGIA DELL’IRC IN ITALIA DELLA SOCIETA’ ITALIANA DI NEFROLOGIA) NELLA POPOLAZIONE AFFETTA DA IRC IN TERAPIA CONSERVATIVA. DATI PRELIMINARI 67
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 67
Physical performance and clinical outcomes in dialysis patients: a secondary analysis of the excite trial 66
L'anziano dializzato " solo ". 66
The effect of tumor necrosis factor antagonists on functional aortic stiffening 66
Diagnosis of renovascular disease by extra-end intrarenal doppler parameters 65
LE NUOVE SOLUZIONI IN DIALISI PERITONEALE 65
Pyelonephritis: Epidemiology, pathogenesis and managemen 65
Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial 65
THE ENDOGENOUS INHIBITOR OFF e NOs ASIMMETRIC DIMETHYLARGININE (ADMA) IS HIGHER IN CAPD THAN IN HD PATIENTS 64
High Variability of Fabry Disease Manifestations in an Extended Italian Family 64
Digoxin and Hypermagnesuria 64
Oi Dialogoi in Dialisi Peritoneale 64
Prevalence and progression of cardiovascular calcifications in peritoneal dialysis patients: A prospective study 63
Color Doppler ultrasound and arteriovenous fistulas for hemodialysis. 63
Prospective Study of Neuropeptide Y as an Adverse Cardiovascular Risk Factor in End-Stage Renal Disease 63
Juvenile renal cell carcinoma as first manifestation of von Hippel-Lindau disease 63
GESTIONE CLINICA DELL’IRC: DATI CAMPANO-SICILIANI DELLO STUDIO TABLE 63
Exit-site infetto con Proud-Flesh:quale terapia? 63
Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients 63
Totale 9.242
Categoria #
all - tutte 55.896
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.896


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.073 0 0 0 34 365 39 168 10 217 12 175 53
2021/20221.678 225 251 4 22 263 12 246 63 166 1 41 384
2022/20232.295 250 69 36 182 217 458 5 379 594 15 73 17
2023/2024960 62 204 63 61 34 107 26 51 4 38 206 104
2024/20253.779 35 627 241 160 821 400 44 153 331 420 228 319
2025/20262.258 419 208 1.535 96 0 0 0 0 0 0 0 0
Totale 15.568